Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $3.90 million which beat the analyst consensus estimate of $3.52 million by 10.80 percent. This is a 229.95 percent increase over sales of $1.18 million the
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $3.90 million which beat the analyst consensus estimate of $3.52 million by 10.80 percent. This is a 229.95 percent increase over sales of $1.18 million the same period last year.